Capital CS Group’s Eli Lilly LLY Stock Holding History

Capital CS Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,530	Closed	-$725K	–	67
2022 Q1	$725K	Sell	2,530 -1,855	-42%	-$477K	0.63%	22
2021 Q4	$1.21M	Buy	+4,385	New	+$1.11M	0.95%	9

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital CS Group's LLY Position: Q2 2022 in Review

Capital CS Group sold out of Eli Lilly (LLY) in Q2 2022, closing a stake of 2,530 shares — an estimated $725K sold.

Capital CS Group first reported a position in LLY in Q4 2021 and held it in 2 quarters. The position peaked at $1.21M in Q4 2021. 2,446 funds tracked by Wall St. Rank hold LLY as of Q2 2022.

Capital CS Group reported no remaining Eli Lilly position as of Q2 2022 after selling out during the quarter.
Capital CS Group sold 2,530 Eli Lilly shares in Q2 2022, an estimated $725K.
Capital CS Group first reported a position in Eli Lilly in Q4 2021 and held it in 2 quarters.
Capital CS Group's Eli Lilly position peaked at $1.21M in Q4 2021.
2,446 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.

Based on Capital CS Group's 13F filing for Q2 2022, filed 19 Jul 2022.